FDA classified a device failure involving ERBE as Class 2 on August 27, 2026.
1 report, 1 independent
Updated Aug 27
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA classified a device failure involving ERBE as Class 2 on August 27, 2026.
Who's involved
What this event is mainly aboutFDAERBE
Keep exploring
The entities involved
Related events
- FDA released a warning letter regarding device failures involving Beta Bionics, Inc.
- FDA classified a Covidien product recall as Class 2 action, while Health Canada reviewed the related manufacturing site action.
- Beta Bionics, Inc. is accused of failing to accurately describe observations made by the FDA.